Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study

Adrian L. Lopresti; Michael Maes; Garth Maker; Sean Hood; Peter D. Drummond

doi:10.1016/j.jad.2014.06.001

Related publications

Article2014

Curcumin for the treatment of major depres- sion: A randomised, double-blind, placebo controlled study

Adrian L. Lopresti, Michael Maes, Garth Maker, Sean Hood, Peter D. Drummond

Article2018

Add-on Treatment with Curcumin Has Antidepressive Effects in Thai Patients with Major Depression: Results of a Randomized Double-Blind Placebo-Controlled Study

Buranee Kanchanatawan, Sookjaroen Tangwongchai, Atapol Sughondhabhirom, Siriluck Suppapitiporn, Solaphat Hemrunrojn, André F. Carvalho, Michael Maes

Article2016

The efficacy of minocycline as an adjunctive treatment for major depressive disorder; a double blind, randomised, placebo controlled trial

Olivia Dean, Michael Maes, Melanie M. Ashton, Lesley Berk, Buranee Kanchanatawan, Atapol Sughondhabirom, Sookjaroen Tangwongchai, Chirk Jenn Ng, Nathan Dowling, Gin S. Malhi, Michael Berk

Article2014

Protocol and Rationale-The Efficacy of Minocycline as an Adjunctive Treatment for Major Depressive Disorder: A Double Blind, Randomised, Placebo Controlled Trial

Olivia Dean, Michael Maes, Melanie M. Ashton, Lesley Berk, Buranee Kanchanatawan, Atapol Sughondhabirom, Sookjareon Tangwongchai, Chee H. Ng, Nathan Dowling, Gin S. Malhi, Michael Berk

Article2020

<scp>Double‐blind</scp>, <scp>placebo‐controlled</scp> study of lurasidone monotherapy for the treatment of bipolar I depression

Tadafumi Kato, Jun Ishigooka, Mari Miyajima, Kei Watabe, Tomohiro Fujimori, Takahiro Masuda, Teruhiko Higuchi, Eduard Vieta